Advertisement

Targeting Inflammatory Processes for Optimization of Cartilage Homeostasis and Repair Techniques

  • Marjolein M. J. Caron
  • Tim J. M. Welting
  • Lodewijk W. van Rhijn
  • Pieter J. Emans
Chapter

Abstract

The outcome of cartilage repair techniques is often hampered by unwanted ossification (e.g. intralesional osteophytes) at the site of the repaired cartilage. Furthermore, stimulating progenitor cells towards chondrocytes and locking them in their desired state is another important hinge point in cartilage repair techniques. Studying the cartilage formation process by endochondral ossification may provide important clues which further enhance cartilage repair techniques in general and may provide crucial information to prevent unwanted ossification in particular. During endochondral ossification mesenchymal progenitors differentiate into proliferative chondrocytes which gradually further differentiate into hypertrophic chondrocytes and finally die by apoptosis; the remaining scaffold is mineralised towards bone. This process takes place in growth plates, during fracture healing and in part during development of articular cartilage, where the endochondral ossification halts at the chondrogenic phase. While inflammation is generally regarded as a negative factor for joint homeostasis and cartilage development, it is also known that inflammation is the first and essential phase of tissue repair in general and bone fracture healing via endochondral ossifcation indeed also depends on haematoma formation and subsequent inflammatory microenvironment. Recently, a growing body of experimental evidence has been published, showing that inflammatory molecules (e.g. NF-κB, COX-2, iNOS, TNFα, interleukins) and their down-stream pathways are not only associated with cartilage degeneration, but are also crucially involved in the initiation of the chondrogenic differentiation process and regulation of cartilage hypertrophy and mineralization. The data described in these reports suggest that one could use these inflammatory pathways for cartilage regenerative medicine, as the initiation of chondrogenic differentiation is a crucial moment for progenitor cell-based cartilage repair techniques. Furthermore, targeting inflammatory mediators may also provide a potential pharmacological approach to prevent or decrease chondrocyte hypertrophic differentiation and subsequent bone formation (e.g. intralesional osteophytes) in cartilage repair techniques.

This chapter describes important characteristics of hyaline articular cartilage, drawbacks of current cartilage repair techniques, the process of endochondral ossification and how inflammation related molecules are involved in different phases of endochondral ossification. In addition, this chapter discusses how better insight into these pathways may provide novel molecular tools to modulate chondrogenesis in cartilage regenerative medicine.

Keywords

Cartilage repair Intralesional osteophyte Inflammation Chondrogenesis Progenitor cells NF-κB COX-2 

Notes

Acknowledgements

This work is financially supported by the Dutch Arthritis Association (grant LLP14) (http://www.reumafonds.nl) and the Dutch Stichting Annafonds|NOREF (grants 07/07 and 08/42) (http://www.annafonds.nl). The authors also thank D.A.M Surtel and A. Cremers.

References

  1. 1.
    Buckwalter J, Mankin H. Articular cartilage: tissue design and chondrocyte matrix interactions. Instr Cours Lect. 1998;47:487–504.Google Scholar
  2. 2.
    Hasler EM, Herzog W, Wu JZ, et al. Articular cartilage biomechanics: theoretical models, material properties, and biosynthetic response. Crit Rev Biomed Eng. 1999;27:415–88.PubMedGoogle Scholar
  3. 3.
    Mankin H, Mow V, Buckwalter J. Articular cartilage structure, composition, and functioned. Rosemont: AAOS; 2000.Google Scholar
  4. 4.
    Poole AR, Kojima T, Yasuda T, et al. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res. 2001;(391 Suppl):S26–33.Google Scholar
  5. 5.
    Moreira-Teixeira LS, Georgi N, Leijten J, et al. Cartilage tissue engineering. Endocr Dev. 2011;21:102–15.PubMedGoogle Scholar
  6. 6.
    Aydelotte MB, Greenhill RR, Kuettner KE. Differences between sub-populations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism. Connect Tissue Res. 1988;18:223–34.PubMedGoogle Scholar
  7. 7.
    Schenk R, Eggli P, Hunziker E. Articular cartilage morphologyed. New York: Raven Press; 1986.Google Scholar
  8. 8.
    Curl WW, Krome J, Gordon ES, et al. Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy. 1997;13:456–60.PubMedGoogle Scholar
  9. 9.
    Hjelle K, Solheim E, Strand T, et al. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18:730–4.PubMedGoogle Scholar
  10. 10.
    Dowthwaite GP, Bishop JC, Redman SN, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci. 2004;117:889–97.PubMedGoogle Scholar
  11. 11.
    Park Y, Sugimoto M, Watrin A, et al. BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel. Osteoarthritis Cartilage. 2005;13:527–36.PubMedGoogle Scholar
  12. 12.
    Emans PJ, Surtel DA, Frings EJ, et al. In vivo generation of cartilage from periosteum. Tissue Eng. 2005;11:369–77.PubMedGoogle Scholar
  13. 13.
    Mankin H, Mow V, Buckwalter J. Articular cartilage repair and osteoarthritised. Rosemont: American Academy of Orthopaedic Surgeons; 2000.Google Scholar
  14. 14.
    Hunter W. Of the structure and disease of articulating cartilages. 1743. Clin Orthop Relat Res. 1995;317:3–6.PubMedGoogle Scholar
  15. 15.
    Dickhut A, Pelttari K, Janicki P, et al. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol. 2009;219:219–26.PubMedGoogle Scholar
  16. 16.
    van Osch GJ, Brittberg M, Dennis JE, et al. Cartilage repair: past and future–lessons for regenerative medicine. J Cell Mol Med. 2009;13:792–810.PubMedGoogle Scholar
  17. 17.
    van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage. 2012;20:223–32.PubMedGoogle Scholar
  18. 18.
    Kamekura S, Kawasaki Y, Hoshi K, et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 2006;54:2462–70.PubMedGoogle Scholar
  19. 19.
    Kawaguchi H. Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. Mol Cells. 2008;25:1–6.PubMedGoogle Scholar
  20. 20.
    Saito T, Fukai A, Mabuchi A, et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med. 2010;16:678–86.PubMedGoogle Scholar
  21. 21.
    Aglietti P, Buzzi R, Bassi PB, et al. Arthroscopic drilling in juvenile osteochondritis dissecans of the medial femoral condyle. Arthroscopy. 1994;10:286–91.PubMedGoogle Scholar
  22. 22.
    Altman RD, Kates J, Chun LE, et al. Preliminary observations of chondral abrasion in a canine model. Ann Rheum Dis. 1992;51:1056–62.PubMedGoogle Scholar
  23. 23.
    Bradley J, Dandy DJ. Results of drilling osteochondritis dissecans before skeletal maturity. J Bone Joint Surg Br. 1989;71:642–4.PubMedGoogle Scholar
  24. 24.
    Furukawa T, Eyre DR, Koide S, et al. Biochemical studies on repair cartilage resurfacing experimental defects in the rabbit knee. J Bone Joint Surg Am. 1980;62:79–89.PubMedGoogle Scholar
  25. 25.
    Insall J. The Pridie debridement operation for osteoarthritis of the knee. Clin Orthop Relat Res. 1974;101:61–7.PubMedGoogle Scholar
  26. 26.
    Kim HK, Moran ME, Salter RB. The potential for regeneration of articular cartilage in defects created by chondral shaving and subchondral abrasion. An experimental investigation in rabbits. J Bone Joint Surg Am. 1991;73:1301–15.PubMedGoogle Scholar
  27. 27.
    Meachim G, Roberts C. Repair of the joint surface from subarticular tissue in the rabbit knee. J Anat. 1971;109:317–27.PubMedGoogle Scholar
  28. 28.
    Mitchell N, Shepard N. The resurfacing of adult rabbit articular cartilage by multiple perforations through the subchondral bone. J Bone Joint Surg Am. 1976;58:230–3.PubMedGoogle Scholar
  29. 29.
    Rae PJ, Noble J. Arthroscopic drilling of osteochondral lesions of the knee. J Bone Joint Surg Br. 1989;71:534.PubMedGoogle Scholar
  30. 30.
    Steinwachs MR, Guggi T, Kreuz PC. Marrow stimulation techniques. Injury. 2008;39 Suppl 1:S26–31.PubMedGoogle Scholar
  31. 31.
    Vachon A, Bramlage LR, Gabel AA, et al. Evaluation of the repair process of cartilage defects of the equine third carpal bone with and without subchondral bone perforation. Am J Vet Res. 1986;47:2637–45.PubMedGoogle Scholar
  32. 32.
    Emans PJ, Pieper J, Hulsbosch MM, et al. Differential cell viability of chondrocytes and progenitor cells in tissue-engineered constructs following implantation into osteochondral defects. Tissue Eng. 2006;12:1699–709.PubMedGoogle Scholar
  33. 33.
    Gallay SH, Miura Y, Commisso CN, et al. Relationship of donor site to chondrogenic potential of periosteum in vitro. J Orthop Res. 1994;12:515–25.PubMedGoogle Scholar
  34. 34.
    Iwasaki M, Nakahara H, Nakase T, et al. Bone morphogenetic protein 2 stimulates osteogenesis but does not affect chondrogenesis in osteochondrogenic differentiation of periosteum-derived cells. J Bone Miner Res. 1994;9:1195–204.PubMedGoogle Scholar
  35. 35.
    Iwasaki M, Nakahara H, Nakata K, et al. Regulation of proliferation and osteochondrogenic differentiation of periosteum-derived cells by transforming growth factor-beta and basic fibroblast growth factor. J Bone Joint Surg Am. 1995;77:543–54.PubMedGoogle Scholar
  36. 36.
    Iwasaki M, Nakata K, Nakahara H, et al. Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology. 1993;132:1603–8.PubMedGoogle Scholar
  37. 37.
    Nakahara H, Bruder SP, Goldberg VM, et al. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop Relat Res. 1990;259:223–32.PubMedGoogle Scholar
  38. 38.
    Nakahara H, Dennis JE, Bruder SP, et al. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res. 1991;195:492–503.PubMedGoogle Scholar
  39. 39.
    Nakahara H, Goldberg VM, Caplan AI. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res. 1991;9:465–76.PubMedGoogle Scholar
  40. 40.
    Nakata K, Nakahara H, Kimura T, et al. Collagen gene expression during chondrogenesis from chick periosteum-derived cells. FEBS Lett. 1992;299:278–82.PubMedGoogle Scholar
  41. 41.
    O’Driscoll SW, Recklies AD, Poole AR. Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J Bone Joint Surg Am. 1994;76:1042–51.PubMedGoogle Scholar
  42. 42.
    Bouwmeester SJ, Beckers JM, Kuijer R, et al. Long-term results of rib perichondrial grafts for repair of cartilage defects in the human knee. Int Orthop. 1997;21:313–7.PubMedGoogle Scholar
  43. 43.
    Homminga GN, Bulstra SK, Bouwmeester PS, et al. Perichondral grafting for cartilage lesions of the knee. J Bone Joint Surg Br. 1990;72:1003–7.PubMedGoogle Scholar
  44. 44.
    Homminga GN, Bulstra SK, Kuijer R, et al. Repair of sheep articular cartilage defects with a rabbit costal perichondrial graft. Acta Orthop Scand. 1991;62:415–8.PubMedGoogle Scholar
  45. 45.
    O’Driscoll SW, Keeley FW, Salter RB. The chondrogenic potential of free autogenous periosteal grafts for biological resurfacing of major full-thickness defects in joint surfaces under the influence of continuous passive motion. An experimental investigation in the rabbit. J Bone Joint Surg Am. 1986;68:1017–35.PubMedGoogle Scholar
  46. 46.
    O’Driscoll SW, Keeley FW, Salter RB. Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. J Bone Joint Surg Am. 1988;70:595–606.PubMedGoogle Scholar
  47. 47.
    O’Driscoll SW, Saris DB, Ito Y, et al. The chondrogenic potential of periosteum decreases with age. J Orthop Res. 2001;19:95–103.PubMedGoogle Scholar
  48. 48.
    Skoog T, Johansson SH. The formation of articular cartilage from free perichondrial grafts. Plast Reconstr Surg. 1976;57:1–6.PubMedGoogle Scholar
  49. 49.
    Vachon A, McIlwraith CW, Trotter GW, et al. Neochondrogenesis in free intra-articular, periosteal, and perichondrial autografts in horses. Am J Vet Res. 1989;50:1787–94.PubMedGoogle Scholar
  50. 50.
    Zarnett R, Salter RB. Periosteal neochondrogenesis for biologically resurfacing joints: its cellular origin. Can J Surg. 1989;32:171–4.PubMedGoogle Scholar
  51. 51.
    Easley ME, Scranton Jr PE. Osteochondral autologous transfer system. Foot Ankle Clin. 2003;8:275–90.PubMedGoogle Scholar
  52. 52.
    Gross AE, McKee NH, Pritzker KP, et al. Reconstruction of skeletal deficits at the knee. A comprehensive osteochondral transplant program. Clin Orthop Relat Res. 1983;174:96–106.PubMedGoogle Scholar
  53. 53.
    Horas U, Schnettler R, Pelinkovic D, et al. Osteochondral transplantation versus autogenous chondrocyte transplantation. A prospective comparative clinical study. Chirurg. 2000;71:1090–7.PubMedGoogle Scholar
  54. 54.
    Onstott AT, Moczo A, Harris NL. Osteochondral autotransfer–newer treatment for chondral defects. AORN J. 2000;71(843–845):848–51.Google Scholar
  55. 55.
    Convery FR, Meyers MH, Akeson WH. Fresh osteochondral allografting of the femoral condyle. Clin Orthop Relat Res. 1991;273:139–45.PubMedGoogle Scholar
  56. 56.
    Czitrom AA, Keating S, Gross AE. The viability of articular cartilage in fresh osteochondral allografts after clinical transplantation. J Bone Joint Surg Am. 1990;72:574–81.PubMedGoogle Scholar
  57. 57.
    Garrett JC. Treatment of osteochondral defects of the distal femur with fresh osteochondral allografts: a preliminary report. Arthroscopy. 1986;2:222–6.PubMedGoogle Scholar
  58. 58.
    Garrett JC. Fresh osteochondral allografts for treatment of articular defects in osteochondritis dissecans of the lateral femoral condyle in adults. Clin Orthop Relat Res. 1994;303:33–7.PubMedGoogle Scholar
  59. 59.
    Garrett JC. Osteochondral allografts for reconstruction of articular defects of the knee. Instr Course Lect. 1998;47:517–22.PubMedGoogle Scholar
  60. 60.
    Ghazavi MT, Pritzker KP, Davis AM, et al. Fresh osteochondral allografts for post-traumatic osteochondral defects of the knee. J Bone Joint Surg Br. 1997;79:1008–13.PubMedGoogle Scholar
  61. 61.
    Gross AE, Aubin P, Cheah HK, et al. A fresh osteochondral allograft alternative. J Arthroplasty. 2002;17:50–3.PubMedGoogle Scholar
  62. 62.
    Brittberg M. Autologous chondrocyte implantation–technique and long-term follow-up. Injury. 2008;39 Suppl 1:S40–9.PubMedGoogle Scholar
  63. 63.
    Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889–95.PubMedGoogle Scholar
  64. 64.
    Brittberg M, Peterson L, Sjogren-Jansson E, et al. Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J Bone Joint Surg Am. 2003;85-A Suppl 3:109–15.PubMedGoogle Scholar
  65. 65.
    Bartlett W, Skinner JA, Gooding CR, et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br. 2005;87:640–5.PubMedGoogle Scholar
  66. 66.
    Harris JD, Siston RA, Brophy RH, et al. Failures, re-operations, and complications after autologous chondrocyte implantation–a systematic review. Osteoarthritis Cartilage. 2011;19:779–91.PubMedGoogle Scholar
  67. 67.
    Pietschmann MF, Niethammer TR, Horng A, et al. The incidence and clinical relevance of graft hypertrophy after matrix-based autologous chondrocyte implantation. Am J Sports Med. 2012;40:68–74.PubMedGoogle Scholar
  68. 68.
    Cole BJ, Farr J, Winalski CS, et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med. 2011;39:1170–9.PubMedGoogle Scholar
  69. 69.
    Vasiliadis HS, Danielson B, Ljungberg M, et al. Autologous chondrocyte implantation in cartilage lesions of the knee: long-term evaluation with magnetic resonance imaging and delayed gadolinium-enhanced magnetic resonance imaging technique. Am J Sports Med. 2010;38:943–9.PubMedGoogle Scholar
  70. 70.
    Abad V, Meyers JL, Weise M, et al. The role of the resting zone in growth plate chondrogenesis. Endocrinology. 2002;143:1851–7.PubMedGoogle Scholar
  71. 71.
    Karlsson C, Lindahl A. Articular cartilage stem cell signalling. Arthritis Res Ther. 2009;11:121.PubMedGoogle Scholar
  72. 72.
    Emans PJ, Caron MMJ, van Rhijn LW, et al. Cartilage tissue engineering; lessons learned from periosteum. Tissue Sci Eng. 2011;S2:002.Google Scholar
  73. 73.
    Medvedev SP, Grigor’eva EV, Shevchenko AI, et al. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev. 2011;20:1099–112.PubMedGoogle Scholar
  74. 74.
    Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568–84.PubMedGoogle Scholar
  75. 75.
    Erlebacher A, Filvaroff EH, Gitelman SE, et al. Toward a molecular understanding of skeletal development. Cell. 1995;80:371–8.PubMedGoogle Scholar
  76. 76.
    Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423:332–6.PubMedGoogle Scholar
  77. 77.
    de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 2001;13:721–7.PubMedGoogle Scholar
  78. 78.
    Lefebvre V, Behringer RR, de Crombrugghe B. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage. 2001;9(Suppl A):S69–75.PubMedGoogle Scholar
  79. 79.
    Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today. 2005;75:200–12.PubMedGoogle Scholar
  80. 80.
    Akiyama H, Chaboissier MC, Martin JF, et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002;16:2813–28.PubMedGoogle Scholar
  81. 81.
    Han Y, Lefebvre V. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol. 2008;28:4999–5013.PubMedGoogle Scholar
  82. 82.
    Lefebvre V, Huang W, Harley VR, et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol. 1997;17:2336–46.PubMedGoogle Scholar
  83. 83.
    Lefebvre V, Li P, de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 1998;17:5718–33.PubMedGoogle Scholar
  84. 84.
    Genzer MA, Bridgewater LC. A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res. 2007;35:1178–86.PubMedGoogle Scholar
  85. 85.
    Jenkins E, Moss JB, Pace JM, et al. The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol. 2005;24:177–84.PubMedGoogle Scholar
  86. 86.
    Oh CD, Maity SN, Lu JF, et al. Identification of SOX9 interaction sites in the genome of chondrocytes. PLoS One. 2010;5:e10113.PubMedGoogle Scholar
  87. 87.
    Rentsendorj O, Nagy A, Sinko I, et al. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene. Biochem J. 2005;389:705–16.PubMedGoogle Scholar
  88. 88.
    Fassler R, Schnegelsberg PN, Dausman J, et al. Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA. 1994;91:5070–4.PubMedGoogle Scholar
  89. 89.
    Li Y, Lacerda DA, Warman ML, et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell. 1995;80:423–30.PubMedGoogle Scholar
  90. 90.
    Nakata K, Ono K, Miyazaki J, et al. Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing alpha 1(IX) collagen chains with a central deletion. Proc Natl Acad Sci USA. 1993;90:2870–4.PubMedGoogle Scholar
  91. 91.
    Vikkula M, Mariman EC, Lui VC, et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell. 1995;80:431–7.PubMedGoogle Scholar
  92. 92.
    Eyre D. Collagen of articular cartilage. Arthritis Res. 2002;4:30–5.PubMedGoogle Scholar
  93. 93.
    Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol. 2001;12:69–78.PubMedGoogle Scholar
  94. 94.
    Lesperance LM, Gray ML, Burstein D. Determination of fixed charge density in cartilage using nuclear magnetic resonance. J Orthop Res. 1992;10:1–13.PubMedGoogle Scholar
  95. 95.
    Venn M, Maroudas A. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. I. Chemical composition. Ann Rheum Dis. 1977;36:121–9.PubMedGoogle Scholar
  96. 96.
    Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect. 1998;47:477–86.PubMedGoogle Scholar
  97. 97.
    Lin Z, Willers C, Xu J, et al. The chondrocyte: biology and clinical application. Tissue Eng. 2006;12:1971–84.PubMedGoogle Scholar
  98. 98.
    Hunziker E. Articular cartilage structure in humans and experimental animalsed. New York: Raven Press; 1992.Google Scholar
  99. 99.
    Aydelotte M, Kuettner K. Heterogeneity of articular chondrocytes and cartilage matrixed. New York: Marcel Dekker; 1992.Google Scholar
  100. 100.
    Radin EL, Martin RB, Burr DB, et al. Effects of mechanical loading on the tissues of the rabbit knee. J Orthop Res. 1984;2:221–34.PubMedGoogle Scholar
  101. 101.
    Hunziker EB. Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Tech. 1994;28:505–19.PubMedGoogle Scholar
  102. 102.
    Arnold MA, Kim Y, Czubryt MP, et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell. 2007;12:377–89.PubMedGoogle Scholar
  103. 103.
    Drissi MH, Li X, Sheu TJ, et al. Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem. 2003;90:1287–98.PubMedGoogle Scholar
  104. 104.
    Linsenmayer TF, Eavey RD, Schmid TM. Type X collagen: a hypertrophic cartilage-specific molecule. Pathol Immunopathol Res. 1988;7:14–9.PubMedGoogle Scholar
  105. 105.
    Zheng Q, Zhou G, Morello R, et al. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol. 2003;162:833–42.PubMedGoogle Scholar
  106. 106.
    Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999;5:623–8.PubMedGoogle Scholar
  107. 107.
    Hess J, Porte D, Munz C, et al. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem. 2001;276:20029–38.PubMedGoogle Scholar
  108. 108.
    Sato M, Morii E, Komori T, et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene. 1998;17:1517–25.PubMedGoogle Scholar
  109. 109.
    Beier F, Ali Z, Mok D, et al. TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol Biol Cell. 2001;12:3852–63.PubMedGoogle Scholar
  110. 110.
    Zhang M, Xie R, Hou W, et al. PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation. J Cell Sci. 2009;122:1382–9.PubMedGoogle Scholar
  111. 111.
    St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999;13:2072–86.PubMedGoogle Scholar
  112. 112.
    Bitgood MJ, McMahon AP. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol. 1995;172:126–38.PubMedGoogle Scholar
  113. 113.
    Long F, Zhang XM, Karp S, et al. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development. 2001;128:5099–108.PubMedGoogle Scholar
  114. 114.
    Vortkamp A, Lee K, Lanske B, et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 1996;273:613–22.PubMedGoogle Scholar
  115. 115.
    Yoon BS, Pogue R, Ovchinnikov DA, et al. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development. 2006;133:4667–78.PubMedGoogle Scholar
  116. 116.
    Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. J Cell Biochem. 2004;93:93–103.PubMedGoogle Scholar
  117. 117.
    Urist MR. Bone: formation by autoinduction. Science. 1965;150:893–9.PubMedGoogle Scholar
  118. 118.
    Chimal-Monroy J, Bravo-Ruiz MT. Diaz de Leon L. Regulation of chondrocyte differentiation by transforming growth factors beta 1, beta 2, beta 3, and beta 5. Ann N Y Acad Sci. 1996;785:241–4.PubMedGoogle Scholar
  119. 119.
    Chimal-Monroy J, Diaz de Leon L. Differential effects of transforming growth factors beta 1, beta 2, beta 3 and beta 5 on chondrogenesis in mouse limb bud mesenchymal cells. Int J Dev Biol. 1997;41:91–102.PubMedGoogle Scholar
  120. 120.
    Ferguson CM, Schwarz EM, Puzas JE, et al. Transforming growth factor-beta1 induced alteration of skeletal morphogenesis in vivo. J Orthop Res. 2004;22:687–96.PubMedGoogle Scholar
  121. 121.
    Ferguson CM, Schwarz EM, Reynolds PR, et al. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Endocrinology. 2000;141:4728–35.PubMedGoogle Scholar
  122. 122.
    Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265–72.PubMedGoogle Scholar
  123. 123.
    Lorda-Diez CI, Montero JA, Martinez-Cue C, et al. Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme. J Biol Chem. 2009;284:29988–96.PubMedGoogle Scholar
  124. 124.
    Feng XH, Zhang Y, Wu RY, et al. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev. 1998;12:2153–63.PubMedGoogle Scholar
  125. 125.
    Lagna G, Hata A, Hemmati-Brivanlou A, et al. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 1996;383:832–6.PubMedGoogle Scholar
  126. 126.
    Elford PR, Graeber M, Ohtsu H, et al. Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor beta-2 in the rabbit. Cytokine. 1992;4:232–8.PubMedGoogle Scholar
  127. 127.
    van Beuningen HM, van der Kraan PM, Arntz OJ, et al. Does TGF-beta protect articular cartilage in vivo? Agents Actions Suppl. 1993;39:127–31.PubMedGoogle Scholar
  128. 128.
    van Beuningen HM, van der Kraan PM, Arntz OJ, et al. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest. 1994;71:279–90.PubMedGoogle Scholar
  129. 129.
    Hunziker EB. Growth-factor-induced healing of partial-thickness defects in adult articular cartilage. Osteoarthritis Cartilage. 2001;9:22–32.PubMedGoogle Scholar
  130. 130.
    Aberle H, Bauer A, Stappert J, et al. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16:3797–804.PubMedGoogle Scholar
  131. 131.
    Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 1996;382:638–42.PubMedGoogle Scholar
  132. 132.
    Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843–50.PubMedGoogle Scholar
  133. 133.
    Day TF, Guo X, Garrett-Beal L, et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005;8:739–50.PubMedGoogle Scholar
  134. 134.
    Dong YF, Soung do Y, Schwarz EM, et al. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol. 2006;208:77–86.PubMedGoogle Scholar
  135. 135.
    Hill TP, Spater D, Taketo MM, et al. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005;8:727–38.PubMedGoogle Scholar
  136. 136.
    Akiyama H. Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol. 2008;18:213–9.PubMedGoogle Scholar
  137. 137.
    Akiyama H, Chaboissier MC, Behringer RR, et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci USA. 2004;101:6502–7.PubMedGoogle Scholar
  138. 138.
    Ryu JH, Kim SJ, Kim SH, et al. Regulation of the chondrocyte phenotype by beta-catenin. Development. 2002;129:5541–50.PubMedGoogle Scholar
  139. 139.
    Topol L, Chen W, Song H, et al. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem. 2009;284:3323–33.PubMedGoogle Scholar
  140. 140.
    Yang KG, Saris DB, Verbout AJ, et al. The effect of synovial fluid from injured knee joints on in vitro chondrogenesis. Tissue Eng. 2006;12:2957–64.PubMedGoogle Scholar
  141. 141.
    Saris DB, Dhert WJ, Verbout AJ. Joint homeostasis. The discrepancy between old and fresh defects in cartilage repair. J Bone Joint Surg Br. 2003;85:1067–76.PubMedGoogle Scholar
  142. 142.
    Richter W. Mesenchymal stem cells and cartilage in situ regeneration. J Intern Med. 2009;266:390–405.PubMedGoogle Scholar
  143. 143.
    Einhorn TA. The science of fracture healing. J Orthop Trauma. 2005;19:S4–6.PubMedGoogle Scholar
  144. 144.
    Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003;88:873–84.PubMedGoogle Scholar
  145. 145.
    Grundnes O, Reikeras O. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand. 1993;64:340–2.PubMedGoogle Scholar
  146. 146.
    Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002;84-A:1032–44.PubMedGoogle Scholar
  147. 147.
    Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev. 2008;14(2):179–86.PubMedGoogle Scholar
  148. 148.
    Einhorn TA, Majeska RJ, Rush EB, et al. The expression of cytokine activity by fracture callus. J Bone Miner Res. 1995;10:1272–81.PubMedGoogle Scholar
  149. 149.
    Rundle CH, Wang H, Yu H, et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone. 2006;38:521–9.PubMedGoogle Scholar
  150. 150.
    Pelletier JP, Martel-Pelletier J. The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man. Arthritis Res. 2002;4:13–9.PubMedGoogle Scholar
  151. 151.
    Sofat N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol. 2009;90:463–79.PubMedGoogle Scholar
  152. 152.
    Gelse K, Soder S, Eger W, et al. Osteophyte development–molecular characterization of differentiation stages. Osteoarthritis Cartilage. 2003;11:141–8.PubMedGoogle Scholar
  153. 153.
    van der Kraan PM, van den Berg WB. Osteophytes: relevance and biology. Osteoarthritis Cartilage. 2007;15:237–44.PubMedGoogle Scholar
  154. 154.
    Blaney Davidson EN, Vitters EL, van Beuningen HM, et al. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum. 2007;56:4065–73.PubMedGoogle Scholar
  155. 155.
    van den Berg WB, van Osch GJ, van der Kraan PM, et al. Cartilage destruction and osteophytes in instability-induced murine osteoarthritis: role of TGF beta in osteophyte formation? Agents Actions. 1993;40:215–9.PubMedGoogle Scholar
  156. 156.
    Feng JQ, Xing L, Zhang JH, et al. NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem. 2003;278:29130–5.PubMedGoogle Scholar
  157. 157.
    Ushita M, Saito T, Ikeda T, et al. Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells. Osteoarthritis Cartilage. 2009;17:1065–75.PubMedGoogle Scholar
  158. 158.
    Wu S, Flint JK, Rezvani G, et al. Nuclear factor-kappaB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem. 2007;282:33698–706.PubMedGoogle Scholar
  159. 159.
    Fukui N, Ikeda Y, Ohnuki T, et al. Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem. 2006;281:27229–41.PubMedGoogle Scholar
  160. 160.
    Fukui N, Zhu Y, Maloney WJ, et al. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am. 2003;85-A Suppl 3:59–66.PubMedGoogle Scholar
  161. 161.
    Aung A, Gupta G, Majid G, et al. Osteoarthritic chondrocyte-secreted morphogens induce chondrogenic differentiation of human mesenchymal stem cells. Arthritis Rheum. 2011;63:148–58.PubMedGoogle Scholar
  162. 162.
    Chen CC, Liao CH, Wang YH, et al. Cartilage fragments from osteoarthritic knee promote chondrogenesis of mesenchymal stem cells without exogenous growth factor induction. J Orthop Res. 2012;30:393–400.PubMedGoogle Scholar
  163. 163.
    Crisostomo PR, Wang Y, Markel TA, et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol. 2008;294:C675–82.Google Scholar
  164. 164.
    Caron MM, Emans PJ, Surtel DA, et al. Activation of NF-kappaB/p65 facilitates early chondrogenic differentiation during endochondral ossification. PLoS One. 2012;7:e33467.PubMedGoogle Scholar
  165. 165.
    Zuscik MJ, Hilton MJ, Zhang X, et al. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest. 2008;118:429–38.PubMedGoogle Scholar
  166. 166.
    Henrotin Y, Kurz B, Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage. 2005;13:643–54.PubMedGoogle Scholar
  167. 167.
    Jallali N, Ridha H, Thrasivoulou C, et al. Modulation of intracellular reactive oxygen species level in chondrocytes by IGF-1, FGF, and TGF-beta1. Connect Tissue Res. 2007;48:149–58.PubMedGoogle Scholar
  168. 168.
    Morita K, Miyamoto T, Fujita N, et al. Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification. J Exp Med. 2007;204:1613–23.PubMedGoogle Scholar
  169. 169.
    Cecil DL, Johnson K, Rediske J, et al. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol. 2005;175:8296–302.PubMedGoogle Scholar
  170. 170.
    Handl M, Filova E, Kubala M, et al. Fluorescent advanced glycation end products in the detection of factual stages of cartilage degeneration. Physiol Res. 2007;56:235–42.PubMedGoogle Scholar
  171. 171.
    Huang CY, Hung LF, Liang CC, et al. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro. Eur J Clin Invest. 2009;39:417–28.PubMedGoogle Scholar
  172. 172.
    Kume S, Kato S, Yamagishi S, et al. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res. 2005;20:1647–58.PubMedGoogle Scholar
  173. 173.
    Nah SS, Choi IY, Lee CK, et al. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford). 2008;47:425–31.Google Scholar
  174. 174.
    Welting TJ, Caron MM, Emans PJ, et al. Inhibition of cyclooxygenase-2 impacts chondrocyte hypertrophic differentiation during endochondral ossification. Eur Cell Mater. 2011;22:420–36; discussion 436–27.PubMedGoogle Scholar
  175. 175.
    Arasapam G, Scherer M, Cool JC, et al. Roles of COX-2 and iNOS in the bony repair of the injured growth plate cartilage. J Cell Biochem. 2006;99:450–61.PubMedGoogle Scholar
  176. 176.
    Baldik Y, Diwan AD, Appleyard RC, et al. Deletion of iNOS gene impairs mouse fracture healing. Bone. 2005;37:32–6.PubMedGoogle Scholar
  177. 177.
    Mais A, Klein T, Ullrich V, et al. Prostanoid pattern and iNOS expression during chondrogenic differentiation of human mesenchymal stem cells. J Cell Biochem. 2006;98:798–809.PubMedGoogle Scholar
  178. 178.
    Itoh SS, Ushita M, Ikeda T, Yano F, Ogata N, Chung U, Nakamura K, Kawaguchi H. NF-kappa B family member RelA/p65, a transcription factor of Sox9, is essential for chondrogenic differentiation and skeletal growth. Osteoarthritis Cartilage. 2009;17:S12–3.Google Scholar
  179. 179.
    Wu S, Fadoju D, Rezvani G, et al. Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65. J Biol Chem. 2008;283:34037–44.PubMedGoogle Scholar
  180. 180.
    Kishimoto H, Akagi M, Zushi S, et al. Induction of hypertrophic chondrocyte-like phenotypes by oxidized LDL in cultured bovine articular chondrocytes through increase in oxidative stress. Osteoarthritis Cartilage. 2010;18:1284–90.PubMedGoogle Scholar
  181. 181.
    Nakagawa S, Arai Y, Mazda O, et al. N-acetylcysteine prevents nitric oxide-induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis. J Orthop Res. 2010;28:156–63.PubMedGoogle Scholar
  182. 182.
    Roman-Blas JA, Contreras-Blasco MA, Largo R, et al. Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes. Eur J Pharmacol. 2009;623:125–31.PubMedGoogle Scholar
  183. 183.
    Csaki C, Keshishzadeh N, Fischer K, et al. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol. 2008;75:677–87.PubMedGoogle Scholar
  184. 184.
    Liu FC, Hung LF, Wu WL, et al. Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res Ther. 2010;12:R167.PubMedGoogle Scholar
  185. 185.
    Shakibaei M, Csaki C, Nebrich S, et al. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol. 2008;76:1426–39.PubMedGoogle Scholar
  186. 186.
    Chowdhury TT, Bader DL, Lee DA. Dynamic compression counteracts IL-1beta induced iNOS and COX-2 activity by human chondrocytes cultured in agarose constructs. Biorheology. 2006;43:413–29.PubMedGoogle Scholar
  187. 187.
    Fischer J, Dickhut A, Rickert M, et al. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum. 2010;62:2696–706.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Marjolein M. J. Caron
    • 1
  • Tim J. M. Welting
    • 1
  • Lodewijk W. van Rhijn
    • 1
  • Pieter J. Emans
    • 2
  1. 1.Department of Orthopaedic SurgeryCAPHRI School for Public Health and Primary Care, Maastricht University Medical CenterMaastrichtThe Netherlands
  2. 2.Department of Orthopaedic SurgeryCAPHRI School for Public Health and Primary Care, Maastricht University Medical CenterMaastrichtThe Netherlands

Personalised recommendations